)
VITA Group have been hurt by rumours of a Telstra buy back of its high performing stores which sent its share price sharply downwards.
ERM Power took a 226 per cent hit to its profits although it has forecast a return to solid margins.
And both Impedimed and Capilano Honey have been spending money on research and development, with the end game for each likely to see a turnaround in their performances.
|
|
CLICK BELOW FOR THIS YEAR'S TOP 50
Click here to return to the 2017 Top Companies home page
Enjoyed this article?
Don't miss out on the knowledge and insights to be gained from our daily news and features.
Subscribe today to unlock unlimited access to in-depth business coverage, expert analysis, and exclusive content across all devices.
Support independent journalism and stay informed with stories that matter to you.
)
)
)
)
)
